HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1

Last updated: June 17, 2025
Sponsor: Yale University
Overall Status: Completed

Phase

N/A

Condition

Hiv

Treatment

IMB-motivational interviewing (MI) techniques (IMB-MI)

Clinical Study ID

NCT05560932
Justice 090622
P01 AA029545-03 sub 9238
P01AA029545
P01AA029545-03
  • Ages > 18
  • All Genders

Study Summary

This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationale is that any alcohol use may interact with medications in serious ways leading to adverse outcomes, including bothersome symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • participants in both Veterans Aging Cohort Study (VACS) and Medications, Alcohol,and Substance use in HIV (MASH) studies

  • prescribed 5 or more medications AND who either have a positive PEth value (8+) or aself-reported AUDIT-C value consistent with current alcohol use (score >0)

Exclusion

Exclusion Criteria:

  • Alcohol use disorder (AUD) diagnosis in the past 12 months or who test positive forAUD on the Alcohol Symptom Checklist for moderate or severe AUD (score of 4 or more)

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: IMB-motivational interviewing (MI) techniques (IMB-MI)
Phase:
Study Start date:
March 06, 2023
Estimated Completion Date:
January 04, 2024

Study Description

Additional outcomes were added at results entry.

Connect with a study center

  • West Haven CT Veterans Administration

    West Haven, Connecticut 06516
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.